Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Hematology"
DOI: 10.1007/s12185-020-02989-5
Abstract: We have read with great interest the paper of Izutsu et al., referring to the data of the AUGMENT phase III clinical trial that report the benefit of lenalidomide plus rituximab (R-Len) for relapsed refractory… read more here.
Keywords: relapsed refractory; six cycles; complete metabolic; metabolic remission ... See more keywords
Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of 223Ra Therapy
Sign Up to like & getrecommendations! Published in 2025 at "Diagnostics"
DOI: 10.3390/diagnostics15162007
Abstract: Background/Objectives: In patients with metastatic castration-resistant prostate cancer (mCRPC) and osseous metastases only, 223Radium therapy represents a valuable therapeutic option. Bone scintigraphy (BS) is typically performed to assess metastasis load, with the BS-derived automated bone… read more here.
Keywords: therapy; absi; six cycles; three six ... See more keywords